Retinopathy of prematurity: recent developments in diagnosis and treatment

References

• Alleman BW, Bell EF, Li L, et al. Individual and center-level Factors affecting mortalitiy among extremely low birth weight children. Pediatrics 2013;132:e175
   PubMed Web of Science ®Google Scholar
• Horbar JD, Carpenter JH, Badger GJ, et al. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics 2012;129(1019):1026
   PubMedGoogle Scholar
• Fruttiger M. Development of the Mouse Retinal Vasculature: Angiogenesis Versus Vasculogenesis. Invest Ophtalmol Vis Sci 2002;43:522-7
   PubMed Web of Science ®Google Scholar
• Gerhardt H, Golding M, Fruttiger M, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003;1163-78
   PubMed Web of Science ®Google Scholar
• Tammela T, Zarkada G, Wallgard E, et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 2008;454:656-60
   PubMed Web of Science ®Google Scholar
• Hellström M, Phng L-K, Hofmann JJ, et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 2007;445:776-80
   PubMed Web of Science ®Google Scholar
• Saharinen P, Eklund L, Miettinen J, et al. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol 2008;10:527-37
   PubMed Web of Science ®Google Scholar
• Chen J, Connor KM, Aderman CM, et al. Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest 2008;118:526-33
   PubMed Web of Science ®Google Scholar
• Lofqvist C, Chen J, Connor KM, et al. IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. Proc Natl Acad Sci USA 2007;104:10589-94
   PubMed Web of Science ®Google Scholar
• Hård A, Liu J, Hellstrom A, et al. Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity. Arch Ophthalmol 2001;98:5804-8
   Google Scholar
• Fruttiger M. Development of the retinal vasculature. Angiogenesis 2007;10:77-88
   PubMedGoogle Scholar
• Hughes S, Yang H, Chan-ling T. Vascularization of the Human Fetal Retina: Roles of Vasculogenesis and Angiogenesis. Invest Ophthalmol Vis Sci 2000;41:1217-28
   PubMed Web of Science ®Google Scholar
• Gariano RF. Special features of human retinal angiogenesis. Eye (Lond) 2010;24:401-7
   Google Scholar
• Chen J, Smith LEH. Retinopathy of prematurity. Angiogenesis 2007;10:133-40
   PubMedGoogle Scholar
• Fleck BW, McIntosh N. Pathogenesis of retinopathy of prematurity and possible preventive strategies. Early Hum Dev 2008;84:83-8
   PubMed Web of Science ®Google Scholar
• Tin W, Milligan DWA, Pennefather P, et al. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonantal Ed 2001;84:106-10
   PubMed Web of Science ®Google Scholar
• Stone J, Chan-ling T, Pe J, et al. Roles of Vascular Endothelial Growth Factor and Astrocyte Degeneration in the Genesis of Retinopathy of Prematurity. Invest Ophthalmol Vis Sci 1996;37:290-9
   PubMed Web of Science ®Google Scholar
• Rivera JC, Sapieha P, Joyal J-S, et al. Understanding retinopathy of prematurity: update on pathogenesis. Neonatology 2011;100:343-53
   PubMed Web of Science ®Google Scholar
• Hellström A, Smith LEH, Dammann O. 2013;Retinopathy of prematurity. Lancet 2013 382:1445-57
   Google Scholar
• Vaucher YE, Peralta-Carcelen M, Finer NN, et al. Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. N Engl J Med 2012;367:2495-504
   PubMed Web of Science ®Google Scholar
• Schmidt B, Whyte RK, Asztalos E V, et al. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. Jama 2013;309:2111-20
   PubMed Web of Science ®Google Scholar
• Jandeck C, Kellner U, Lorenz B, Seibert V. Leitlinie zur augenärztlichen Untersuchung von Frühgeborenen. Ophthalmologe 2008;105:955-64
   PubMedGoogle Scholar
• Pelken L, Maier RF. [Risk factors and prevention of retinopathy of prematurity]. Ophthalmologe 2008;105:1108-13
   PubMed Web of Science ®Google Scholar
• Lofqvist C, Andersson E, Sigurdsson J, et al. Longitudinal Postnatal Weight and Insulin-like Growth Factor I Measurements in the Prediction of Retinopathy of Prematurity. Arch Ophthalmol 2006;124:1711-18
   PubMedGoogle Scholar
• Wu C, VanderVeen DK, Hellström A, et al. Longitudinal Postnatal Weight Measurements for the Prediction of Retinopathy of Prematurity. Arch Ophthalmol 2010;128:443-7
   PubMedGoogle Scholar
• Löfqvist C, Hansen-Pupp I, Andersson E, et al. Validation of a New Retinopathy of Prematurity Screening Method Monitoring Longitudinal Postnatal Weight and Insulin-like Growth Factor I. Arch Ophthalmol 2009;127:622-7
   PubMedGoogle Scholar
• Hard A-L, Löfqvist C, Filho JB, et al. Predicting Proliferative Retinopathy in a Brazilian Population of Preterm Infants With the Screening Algorithm WINROP. Arch Ophthalmol 2010;128:1432-6
   PubMedGoogle Scholar
• An International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005;123:991-9
   PubMedGoogle Scholar
• Committee for the Classification of Retinopathy of Prematurity. An international classification of Retinopathy of Prematurity. Arch Ophthalmol 1984;102:1130-4
   PubMed Web of Science ®Google Scholar
• Mintz-Hittner HA, Kennedy KA, Chuang AZ, et al. Efficacy of Intravitreal Bevacizumab for stage 3+ Retinopathy of Prematurity. N Engl J Med 2011;364:603-15
   PubMed Web of Science ®Google Scholar
• Early treatment of Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment of retinopathy randomized trial. Arch Ophthalmol 2003;121:1684-96
   PubMedGoogle Scholar
• Lorenz B, Bock M, Müller HM, et al. Telemedicine based screening of infants at risk for retinopathy of prematurity. Stud Heal Technol Inf 1999;64:155-63
   PubMedGoogle Scholar
• Schwartz SD, Harrison SA, Ferrone PJ, et al. Telemedical evaluation and management of retinopathy of prematurity using a fiberoptic digital fundus camera. Ophthalmology 2000;107:25-8
   PubMed Web of Science ®Google Scholar
• Seibert V, Woldt C. Weitwinkelfundusdokumentation bei Retinopathia praematurorum. Ophthalmologe 2001;98:960-3
   PubMedGoogle Scholar
• Yen KG, Hess D, Burke B, et al. Telephotoscreening to detect retinopathy of prematurity: preliminary study of the optimum time to employ digital fundus camera imaging to detect ROP. J Am Assoc Pediatr Ophthalmol Strabismus 2002;6:64-70
   Google Scholar
• Photographic screening of Retinopathy of Prematurity Study (PHOTO-ROP) Cooperative Group. The photographic screening of retinopathy of prematurity study (PHOTO-ROP): study design and baseline characteristics of enrolled patients. Retina 2006;26:S4-10
   Web of Science ®Google Scholar
• Photographic screening of Retinopathy of Prematurity Study (PHOTO-ROP) Cooperative Group. The photographic screening of retinopathy of prematurity study (PHOTO-ROP): primary outcomes. Retina 2008;28:S47-54
   Web of Science ®Google Scholar
• Chiang MF, Gelman R, Ba LJ, et al. Plus disease in retinopathy of prematurity: an analysis of diagnostic performance. Trans Am Ophthalmol Soc 2007;105:73-85
   PubMedGoogle Scholar
• Lorenz B, Spasovska K, Elflein H, Schneider N. Wide-field digital imaging based telemedicine for screening for acute retinopathy of prematurity (ROP). Six-year results of a multicentre field study. Graefes Arch Clin Exp Ophthalmol 2009;247:1251-62
   PubMed Web of Science ®Google Scholar
• Mukherjee AN, Watts P, Al-Madfai H, et al. Impact of retinopathy of prematurity screening examination on cardiorespiratory indices: a comparison of indirect ophthalmoscopy and Retcam imaging. Ophthalmology 2006;113:1547-52
   PubMed Web of Science ®Google Scholar
• Zepeda-Romero LC, Martinez-Perez ME, Ruiz-Velasco S, et al. Temporary morphological changes in plus disease induced during contact digital imaging. Eye (Lond) 2011;25:1337-40
   PubMed Web of Science ®Google Scholar
• Patel CK, Fung THM, Muqit MMK, et al. Non-contact ultra-wide-field imaging of retinopathy of prematurity using the Optos dual wavelength scanning laser ophthalmoscope. Eye (Lond) 2013;27:589-96
   PubMed Web of Science ®Google Scholar
• Quinn GE, Ying GS, Daniel E, et al. Validity of a telemedicine system for the evaluation of acute-phase retinopathy of prematurity. JAMA Ophthalmol 2014;132:1178-84
   PubMed Web of Science ®Google Scholar
• Vinekar A, Gilbert CE, Dogra M, et al. The KIDROP model of combining strategies for providing retinopathy of prematurity screening in underserved areas in India using wide field imaging, tele-medicine, non-physician graders and smart phone reporting. Indian J Ophthalmol 2014;62:41-9
   PubMed Web of Science ®Google Scholar
• Bernstein PS, Sharifzadeh M, Liu A, et al. Blue-light reflectance imaging of macular pigment in infants and children. Invest Ophthalmol Vis Sci 2013;54:4034-40
   PubMed Web of Science ®Google Scholar
• Gelman R, Jiang L, Du YE, et al. Plus disease in retinopathy of prematurity: pilot study of computer-based and expert diagnosis. J Am Assoc Pediatr Ophthalmol Strabismus 2007;11:532-40
   Google Scholar
• Chiang MF, Gelman R, Martinez-Perez ME, et al. Image analysis for retinopathy of prematurity diagnosis. J Am Assoc Pediatr Ophthalmol Strabismus 2009;13:438-45
   Google Scholar
• Johnson KS, Mills MD, Karp KA, et al. Semiautomated analysis of retinal vessel diameter in retinopathy of prematurity patients with and without plus disease. Am J Ophthalmol 2006;143:723-5
   PubMed Web of Science ®Google Scholar
• Rabinowitz MP, Grunwald JE, Karp KA, et al. Progression to severe retinopathy predicted by retinal vessel diameter between 31 and 34 weeks of postconception age. Arch Ophthalmol 2014;125:1495-500
   Google Scholar
• Johnson KS, Mills MD, Karp KA, Grunwald JE. Vessel diameter reduction after retinopathy of prematurity. Am J Ophthalmol 2007;143:1030-2
   PubMed Web of Science ®Google Scholar
• Shah DN, Wilson CM, Ying GS, et al. Comparison of expert graders to computer-assisted image analysis of the retina in retinopathy of prematurity. Br J Ophthalmol 2011;95:1442-5
   PubMed Web of Science ®Google Scholar
• Ghodasra DH, Thuangtong A, Karp KA, et al. The rate of change in retinal vessel width and tortuosity in eyes at risk for retinopathy of prematurity. J Am Assoc Pediatr Ophthalmol Strabismus 2012;16:431-6
   Google Scholar
• Bankhead P, Scholfield CN, McGeown JG, et al. Fast retinal vessel detection and measurement using wavelets and edge location refinement. PLoS One 2012;7:e32435
   Web of Science ®Google Scholar
• Martinez-Perez ME, Hughes AD, Thom SA, et al. Segmentation of blood vessels from red-free and fluorescein retinal images. Med Image Anal 2007;11:47-61
   PubMed Web of Science ®Google Scholar
• Cheung CSY, Butty Z, Tehrani NN, et al. Computer-assisted image analysis of temporal retinal vessel width and tortuosity in retinopathy of prematurity for the assessment of disease severity and treatment outcome. J Am Assoc Pediatr Ophthalmol Strabismus 2011;15:374-80
   Google Scholar
• Wu KY, Wallace DK, Freedman SF. Predicting the need for laser treatment in retinopathy of prematurity using computer-assisted quantitative vascular analysis. J Am Assoc Pediatr Ophthalmol Strabismus 2014;18:114-19
   Google Scholar
• Maier G, Barth P, Pisinger G, et al. A curvature based approach to tortuosity measurement of retinal blood vessels. BioMed Conf Proceedings, Vienna 2013;407-14
   Google Scholar
• Schulenburg WE, Tsanaktsidis G. Variations in the morphology of retinopathy of prematurity in extremely low birthweight infants. Br J Ophthalmol 2004;88:1500-3
   PubMed Web of Science ®Google Scholar
• Ng EY, Lanigan B, O’Keefe M. Fundus fluorescein angiography in the screening for and management of retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 2006;43:85-90
   PubMed Web of Science ®Google Scholar
• Yokoi T, Yokoi T, Kobayashi Y, et al. Evaluation of scleral buckling for stage 4A retinopathy of prematurity by fluorescein angiography. Am J Ophthalmol 2009;148:544-550.e1
   PubMed Web of Science ®Google Scholar
• Lepore D, Molle F, Pagliara MM, et al. Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity. Ophthalmology 2011;118:168-75
   PubMed Web of Science ®Google Scholar
• Purcaro V, Velia P, Baldascino A, et al. Fluorescein angiography and retinal vascular development in premature infants. J Matern Fetal Neonatal Med 2012;25 Suppl 3:53-6
   PubMed Web of Science ®Google Scholar
• Zepeda-Romero LC, Oregon-Miranda AA, Lizarraga-Barrón DS, et al. Early retinopathy of prematurity findings identified with fluorescein angiography. Graefes Arch Clin Exp Ophthalmol 2013;251:2093-7
   PubMed Web of Science ®Google Scholar
• Guagliano R, Barilla D, Bertone C, et al. Fluorescein angiography-based diagnosis for retinopathy of prematurity: expert-non expert comparison. Eur J Ophthalmol 2013;23:881-6
   PubMed Web of Science ®Google Scholar
• Henaine-Berra A, Garcia-Aguirre G, Quiroz-Mercado H, et al. Retinal fluorescein angiographic changes following intravitreal anti-VEGF therapy. J Am Assoc Pediatr Ophthalmol Strabismus 2014;18:120-3
   Google Scholar
• Tahija SG, Hersetyati R, Lam GC, et al. Fluorescein angiographic observations of peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy for zone I and posterior zone II retinopathy of prematurity. Br J Ophthalmol 2014;98:507-12
   PubMed Web of Science ®Google Scholar
• Lepore D, Quinn GE, Molle F, et al. Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings. Ophthalmology 2014;121:1-8
   PubMed Web of Science ®Google Scholar
• Recchia FM, Recchia CC. Foveal dysplasia evident by optical coherence tomography in patients with a history of retinopathy of prematurity. Retina 2006;27:1221-6
   Web of Science ®Google Scholar
• Soong GP, Shapiro MJ, Seiple W, Szlyk JP. Macular structure and vision of patients with macular heterotopia secondary to retinopathy of prematurity. Retina 2008;28:1111-16
   PubMed Web of Science ®Google Scholar
• Villegas VM, Capó H, Cavuoto K, et al. Foveal structure-function correlation in children with history of retinopathy of prematurity. Am J Ophthalmol 2014;158:508-12.e2
   PubMed Web of Science ®Google Scholar
• Wu W-C, Lin R-I, Shih C-P, et al. Visual acuity, optical components, and macular abnormalities in patients with a history of retinopathy of prematurity. Ophthalmology 2012;119:1907-16
   PubMed Web of Science ®Google Scholar
• Joshi MM, Trese MT, Capone A. Optical coherence tomography findings in stage 4A retinopathy of prematurity: a theory for visual variability. Ophthalmology 2006;113:657-60
   PubMed Web of Science ®Google Scholar
• Vinekar A, Avadhani K, Sivakumar M, et al. Understanding clinically undetected macular changes in early retinopathy of prematurity on spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 2011;52:5183-8
   PubMed Web of Science ®Google Scholar
• Vinekar A, Sivakumar M, Shetty R, et al. A novel technique using spectral-domain optical coherence tomography (Spectralis, SD-OCT+HRA) to image supine non-anaesthetized infants: utility demonstrated in aggressive posterior retinopathy of prematurity. Eye (Lond) 2010;24:379-82
   PubMed Web of Science ®Google Scholar
• Chavala SH, Farsiu S, Maldonado RS, et al. Insights into advanced retinopathy of prematurity using handheld spectral domain optical coherence tomography imaging. Ophthalmology 2009;116:2448-56
   PubMed Web of Science ®Google Scholar
• Muni RH, Kohly RP, Charonis AC, et al. Retinoschisis Detected With Handheld Spectral-Domain Optical Coherence Tomography in Neonates With Advanced Retinopathy of Prematurity. Arch Ophthalmol 2014;128:57-62
   Google Scholar
• Maldonado RS, Connell RV, Sarin N, et al. Dynamics of Human Foveal Development. Ophthalmology 2011;118:2315-25
   PubMed Web of Science ®Google Scholar
• Dubis AM, Hansen BR, Cooper RF, et al. Relationship between the foveal avascular zone and foveal pit morphology. Invest Ophthalmol Vis Sci 2012;53:1628-36
   PubMed Web of Science ®Google Scholar
• Vajzovic L, Hendrickson AE, Clark LA, et al. Maturation of the human fovea: correlation of Spectral-Domain optical coherence tomography findings with histology. Am J Ophthalmol 2013;154:779-89
   Web of Science ®Google Scholar
• Dubis AM, Subramaniam CD, Godara P, et al. Subclinical macular findings in infants screened for retinopathy of prematurity with spectral-domain optical coherence tomography. Ophthalmology 2013;120:1665-71
   PubMed Web of Science ®Google Scholar
• Maldonado RS, O’Connell R V, Ascher SB, et al. Spectral-Domain Optical coherence tomographic assessment of severity of Cystoid Macular Edema in Retinopathy of Prematurity. Arch Ophthalmol 2012;130:569-78
   PubMedGoogle Scholar
• Moreno TA, O’Connell RV, Chiu SJ, et al. Choroid development and feasibility of choroidal imaging in the preterm and term infants utilizing SD-OCT. Invest Ophthalmol Vis Sci 2013;54:4140-7
   PubMed Web of Science ®Google Scholar
• Tong AY, El-Dairi M, Maldonado RS, et al. Evaluation of optic nerve development in preterm and term infants using handheld spectral-domain optical coherence tomography. Ophthalmology 2014;121:1818-26
   PubMed Web of Science ®Google Scholar
• Maldonado RS, Yuan E, Tran-Viet D, et al. Three-dimensional assessment of vascular and perivascular characteristics in subjects with retinopathy of prematurity. Ophthalmology 2014;121:1289-96
   PubMed Web of Science ®Google Scholar
• Autrata R, Krejcírová I, Senková K, et al. Intravitreal pegaptanib combined with diode laser therapy for stage 3+ retinopathy of prematurity in zone I and posterior zone II. Eur J Ophthalmol 2012;22:687-94
   PubMed Web of Science ®Google Scholar
• Mota Á. Combination of intravitreal ranibizumab and laser photocoagulation for aggressive posterior retinopathy of prematurity. Case Rep Ophthalmol 2012;136-41
   PubMedGoogle Scholar
• Castellanos MA, Schwartz S, García-Aguirre G, Quiroz-Mercado H. Short-term outcome after intravitreal ranibizumab injections for the treatment of retinopathy of prematurity. Br J Ophthalmol 2013;97:816-19
   PubMed Web of Science ®Google Scholar
• Lin CJ, Chen SN, Hwang JF, et al. Intravitreal ranibizumab as salvage therapy in an extremely low-birth-weight infant with rush type retinopathy of prematurity. Oman J Ophthalmol 2012;5:184-6
   PubMedGoogle Scholar
• Lorenz B. Bevacizumab bei RPM? Klin Monbl Augenheilk 2011;228:488-90
   Google Scholar
• Moshfeghi DM, Berrocal AM. Retinopathy of prematurity in the time of bevacizumab: incorporating the BEAT-ROP results into clinical practice. Ophthalmology 2011;118:1227-8
   PubMed Web of Science ®Google Scholar
• Raizada S, Al Kandari J, Al Sabti K. Will the BEAT-ROP Study Results Really Beat ROP? Invest Ophthalmol Vis Sci 2011;52:9288-9
   PubMed Web of Science ®Google Scholar
• Hu J, Blair MP, Shapiro MJ, et al. Reactivation of retinopathy of prematurity after bevacizumab injection. Arch Ophthalmol 2012;130:1000-6
   PubMed Web of Science ®Google Scholar
• Kusaka S, Shima C, Wada K, et al. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study. Br J Ophthalmol 2008;92:1450-5
   PubMed Web of Science ®Google Scholar
• Honda S, Hirabayashi H, Tsukahara Y, et al. Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2008;246:1061-3
   PubMed Web of Science ®Google Scholar
• Lee BJ, Kim JH, Heo H, et al. Delayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity. Eye (Lond) 2012;26:903-9
   PubMed Web of Science ®Google Scholar
• Geloneck MM, Chuang AZ, Clark WL, et al. Refractive Outcomes Following Bevacizumab Monotherapy Compared with Conventional Laser Treatment: a Randomized Clinical Trial. JAMA Ophthalmol 2014;132:1327-33
   PubMed Web of Science ®Google Scholar
• Harder BC, Schlichtenbrede FC, von Baltz S, et al. Intravitreal Bevacizumab for Retinopathy of Prematurity: refractive Error Results. Am J Ophthalmol 2013;155:1119-24
   PubMed Web of Science ®Google Scholar
• Chen YH, Chen SN, Lien RI, et al. Refractive errors after the use of bevacizumab for the treatment of retinopathy of prematurity: 2-year outcomes. Eye (Lond) 2014;28:1080-7
   PubMed Web of Science ®Google Scholar
• Martinez-Castellanos MA, Schwartz S, Hernandez-Rojas ML, et al. Long-term effect of antiangiogenic therapy for retinopathy of prematurity up to 5 years of follow-up. Retina 2013;33:329-38
   PubMed Web of Science ®Google Scholar
• Saint-Geniez M, Maharaj ASR, Walshe TE, et al. Endogenous VEGF is required for visual function: evidence for a survival role on Müller cells and photoreceptors. PLoS One 2008;3:e3554
   PubMed Web of Science ®Google Scholar
• Miyake T, Sawada O, Kakinoki M, et al. Pharmacokinetics of bevacizumab and its effect on vascular endothelial growth factor after intravitreal injection of bevacizumab in macaque eyes. Invest Ophthalmol Vis Sci 2010;51:1606-8
   PubMed Web of Science ®Google Scholar
• Sato T, Wada K, Arahori H, et al. Serum concentrations of bevacizumab (Avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity. Am J Ophthalmol 2012;153:327-33.e1
   PubMed Web of Science ®Google Scholar
• Banks RE, Forbes MA, Kinsey SE, et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 1998;77:956-64
   PubMed Web of Science ®Google Scholar
• Hörster R, Müther P, Dahlke C, et al. Serum concentrations of vascular endothelial growth factor in an infant treated with ranibizumab for retinopathy of prematurity. Acta Ophthalmol 2012;49:50924
   Google Scholar
• Ryan A, Eppler D, Hagler K. Preclinical safety evaluation of rhuMAb VEGF, an antiangiogenic humanized monoclonal antibody. Toxicol Pathol 1999;27:78-86
   PubMed Web of Science ®Google Scholar
• Benesch M, Windelberg M, Sauseng W. Compassionate use of bevacizumab (Avastin) in children and young adults with refractory or recurrent solid tumors. Ann Oncol 2008;19:807-13
   PubMed Web of Science ®Google Scholar
• Chung EJ, Kim JH, Ahn HS, Koh HJ. Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2007;245:1727-30
   PubMed Web of Science ®Google Scholar
• Mintz-Hittner HA, Kuffel RR. 2008;Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina 2008;28:831-8
   PubMed Web of Science ®Google Scholar
• Lalwani GA, Berrocal AM, Murray TG, et al. Off-Label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of Prematurity. Retina 2008;28:S13-18
   PubMed Web of Science ®Google Scholar
• Quiroz-Mercado H, Martinez-Castellanos MA, Hernandez-Rojas ML, et al. Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity. Retina 2008;28:S19-25
   PubMed Web of Science ®Google Scholar
• Oberacher-Velten IM, Helbig H. VEGF-antikörper in der therapie der frühgeborenen- retinopathie VEGF antibodies as therapy for retinopathy of prematurity. Klin Monbl Augenheilk 2010;227:694-700
   PubMed Web of Science ®Google Scholar
• Nazari H, Modarres M, Parvaresh MM, Ghasemi K. Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage. Graefes Arch Clin Exp Ophthalmol 2010;248:1713-18
   PubMed Web of Science ®Google Scholar
• Ahmed A, Channa R, Durrani J, et al. Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity. Middle East Afr J Ophthalmol 2010;17:264-7
   PubMedGoogle Scholar
• Lee JY, Chae JB, Yang SJ, et al. Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels. Graefes Arch Clin Exp Ophthalmol 2010;248:1257-62
   PubMed Web of Science ®Google Scholar
• Law JC, Recchia FM, Morrison DG, et al. Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity. J Am Assoc Pediatr Ophthalmol Strabismus 2010;14:6-10
   Google Scholar
• Roohipoor R, Ghasemi H, Ghassemi F, et al. Intravitreal bevacizumab in retinopathy of prematurity: an interventional case series. Graefes Arch Clin Exp Ophthalmol 2011;249:1295-301
   PubMed Web of Science ®Google Scholar
• Wutthiworawong B, Thitiratsanont U, Saovaprut C, et al. Combine intravitreal bevacizumab injection with laser treatment for aggressive posterior retinopathy of prematurity (AP-ROP). J Med Assoc Thai 2011;4:515-21
   Google Scholar
• Wu WC, Yeh PT, Chen SN, et al. Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in Taiwan. Ophthalmology 2011;118:176-83
   PubMed Web of Science ®Google Scholar
• Lorenz B, Neutzner R, Andrassi-Darida M, et al. Einsatz von Anti-VEGF bei der akuten Einsatz von Anti-VEGF bei der akuten Frühgeborenenretinopathie. der Augenspiegel 2011;5:32-5; article in german
   Google Scholar
• Choovuthayakorn J, Ubonrat K. Intravitreal bevacizumab injection in advanced retinopathy of prematurity. J Med Assoc Thai 2012;5:570-5
   Google Scholar
• Dani C, Frosini S, Fortunato P, et al. Intravitreal bevacizumab for retinopathy of prematurity as first line or rescue therapy with focal laser treatment. a case series. J Matern Fetal Neonatal Med 2012;25:2194-7
   PubMed Web of Science ®Google Scholar
• Jalali S, Balakrishnan D, Zeynalova Z, et al. Serious adverse events and visual outcomes of rescue therapy using adjunct bevacizumab to laser and surgery for retinopathy of prematurity. The Indian twin cities retinopathy of prematurity screening database report number 5. Arch Dis Child Fetal Neonatal Ed 2013;98:F327-33
   Web of Science ®Google Scholar
• Xu Y, Zhang Q, Kang X, et al. Early vitreoretinal surgery on vascularly active stage 4 retinopathy of prematurity through the preoperative intravitreal bevacizumab injection. Acta Ophthalmol 2013;91:e304-10
   Web of Science ®Google Scholar
• Spandau U, Tomic Z, Ewald U, et al. Time to consider a new treatment protocol for aggressive posterior retinopathy of prematurity? Acta Ophthalmol 2013;91:170-5
   PubMed Web of Science ®Google Scholar
• Şahin A, Şahin M, Cingü AK, et al. Intravitreal bevacizumab monotherapy for retinopathy of prematurity. Pediatr Int 2013;55:599-603
   PubMed Web of Science ®Google Scholar
• Wu WC, Kuo HK, Yeh PT, et al. An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in Taiwan. Am J Ophthalmol 2013;155:150-158.e1
   PubMed Web of Science ®Google Scholar
• Ehmann D, Greve M. Intravitreal bevacizumab for exudative retinal detachment post laser therapy for retinopathy of prematurity. Can J Ophthalmol 2014;49:228-31
   PubMed Web of Science ®Google Scholar
• Kuniyoshi K, Sugioka K, Sakuramoto H, et al. Intravitreal injection of bevacizumab for retinopathy of prematurity. Jpn J Ophthalmol 2014;58:3-237-43
   Web of Science ®Google Scholar
• Harder BC, von Baltz S, Jonas JB, Schlichtenbrede FC. Intravitreal low-dosage bevacizumab for retinopathy of prematurity. Acta Ophthalmol 2014;92:577-81
   PubMed Web of Science ®Google Scholar
• Chhablani J, Rani PK, Balakrishnan D, Jalali S. Unusual adverse choroidal reaction to intravitreal bevacizumab in aggressive posterior retinopathy of prematurity: the Indian twin cities ROP screening (ITCROPS) data base report number 7. Semin Ophthalmol 2014;29:222-5
   PubMed Web of Science ®Google Scholar
• Chen W, Binenbaum G, Karp K, et al. Late recurrence of retinopathy of prematurity after treatment with both intravitreal bevacizumab and laser. J Am Assoc Pediatr Ophthalmol Strabismus 2014;18:402-4
   Google Scholar
• Bancalari A, Schade R, Pena R, Pavez N. Intravitreal bevacizumab as single drug therapy for retinopathy of prematurity in 12 patients. Arch Argent Pediatr 2014;112:160-3
   PubMed Web of Science ®Google Scholar